Drugs for Body Mass Index Quantitative Trait Locus 1 (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show top 50)
(show all 174)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Leuprolide |
Approved, Investigational |
Phase 4 |
|
53714-56-0 |
657181 |
Synonyms:
(D-Leu(6),des-gly-NH2(10),pro-ethylamide(9))-gonadotropin-releasing hormone
ABBOTT-43818
ABBOTT-43818 FREE BASE
ABBOTT-43818|Fensolvi® (leuprolide acetate injectable suspension)|Lupron®|TAP-144
Acetate, leuprolide
CKD-841
Enantone
Leuprolide
Leuprolide acetate
Leuprolide monoacetate
Leuprolide, (DL-leu)-isomer
Leuprolide, (L-leu)-isomer
Leuprorelin
|
Leuprorelin acetate
Leuprorelina
Leuproreline
Leuprorelinum
L-Pyroglutamyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-D-leucyl-L-leucyl-L-arginyl-L-proline ethylamide
Lupron
Monoacetate, leuprolide
NSC-377526
PGlu-his-TRP-ser-tyr-D-leu-leu-arg-pro-NHC2H5
PGlu-his-TRP-ser-tyr-D-leu-leu-arg-pro-nhet
TAP 144
TAP-144
TAP-144 FREE BASE
|
|
2 |
|
Benzocaine |
Approved, Investigational |
Phase 4 |
|
1994-09-7, 94-09-7 |
2337 |
Synonyms:
(P-(Ethoxycarbonyl)phenylamine
4-(Ethoxycarbonyl)aniline
4-(Ethoxycarbonyl)phenylamine
4-Aminobenzoate
4-Aminobenzoate ethyl ester
4-Aminobenzoic acid
4-Aminobenzoic acid ethyl ester
4-Carbethoxyaniline
Acetate, benzocaine
Aethoform
AEZODENT
Amben ethyl ester
Americaine
Anaesthan-syngala
Anaesthesin
Anaesthin
Anestezin
Anesthesin
Anesthesine
Anesthone
ANTHISAN PLUS
AR01
AR-01
Baby anbesol
Bensokain
Benzoak
Benzocaina
BENZOCAINE
Benzocaine acetate
Benzocaine formate
Benzocaine hydrobromide
Benzocaine hydrochloride
Benzocaine methanesulfonate
Benzocainum
BURNEZE
CHILDREN'S CHLORASEPTIC
DEQUACAINE
Dermoplast
Diet ayds
Ethoform
Ethyl 4-aminobenzoate
|
Ethyl 4-aminobenzoic acid
Ethyl aminobenzoate
Ethyl aminobenzoic acid
Ethyl P-aminobenzenecarboxylate
Ethyl p-aminobenzoate
Ethyl p-aminobenzoic acid
Ethyl p-aminophenylcarboxylate
Ethyl p-aminophenylcarboxylic acid
Ethylester kyseliny P-aminobenzoove
Formate, benzocaine
Hurricaine
Hydrobromide, benzocaine
Hydrochloride, benzocaine
Identhesin
Keloform
LANACANE
MEDILAVE
Methanesulfonate, benzocaine
NESTOSYL
Norcain
Norcaine
NSC-41531
NSC-4688
Orabase-b
Ora-jel
ORAJEL
Orthesin
p-(Ethoxycarbonyl)aniline
P-Aminobenzoate
P-Aminobenzoic acid
P-Aminobenzoic acid ethyl ester
Parathesin
Parathesine
p-Carbethoxyaniline
p-Ethoxycarboxylic aniline
Slim mint gum
Solarcaine
Solu H
Topcaine
TYROSOLVEN
TYROZETS
|
|
3 |
|
Tannic acid |
Approved |
Phase 4 |
|
1401-55-4 |
16129878 16129778 |
Synonyms:
Acid, tannic
ácido tánico
Acids, tannic
E181
FEMA NO. 3042
Gallotannic acid
|
Gallotannin
NSC-656273
TANNIC ACID
Tannic acids
Tannins
|
|
4 |
|
Metformin |
Approved |
Phase 4 |
|
1115-70-4, 657-24-9 |
4091 |
Synonyms:
[<sup>14</sup>C]-metformin
1,1-Dimethyl biguanide
1,1-Dimethylbiguanide
1-CARBAMIMIDAMIDO-N,N-DIMETHYLMETHANIMIDAMIDE
Apo-Metformin
BOLAMYN SR
Diabefagos
Diabex
Diaformin
DIAGEMET XL
Dianben
Dimethylbiguanid
Dimethylbiguanide
Dimethylbiguanidine
Dimethyldiguanide
Dimethylguanylguanidine
DMBG
Fortamet
Gen-Metformin
GLUCAMET 500
GLUCAMET 850
GLUCIENT SR
Glucophage
GLUCOPHAGE SR
GLUCOPHAGE XR
Glumetza
Glycon
GLYFORMIN
HCL, Metformin
Hydrochloride, metformin
JANUMET
LA 6023
LA-6023
|
LEDERMETIN
Meguan
METABET SR
Metformin
Metformin HCL
Metformin hydrochloride
Metformina
Metformine
Metforminum
Metiguanide
METSOL
MILFORM
Mylan-Metformin
N(1),N(1)-Dimethylbiguanide
N,N-Dimethylbiguanide
N,N-Dimethyldiguanide
N,N-Dimethylguanylguanidine
N,N-Dimethylimidodicarbonimidic diamide
N1,N1-Dimethylbiguanide
Novo-Metformin
NSC-91485
Nu-Metformin
Obimet
ORABET
PMS-Metformin
Ran-Metformin
Ratio-Metformin
Riomet
Sandoz Metformin
SUKKARTO SR
Teva-Metformin
XLA399
|
|
5 |
|
Levonorgestrel |
Approved, Investigational |
Phase 4 |
|
797-63-7 |
13109 |
Synonyms:
(-)-13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one
(-)-13-Ethyl-17-hydroxy-18,19-dinor-17a-pregn-4-en-20-yn-3-one
(-)-13-Ethyl-17-hydroxy-18,19-dinor-17α-pregn-4-en-20-yn-3-one
(+-)-Norgestrel
(8R,9S,10R,13S,14S,17R)-13-ETHYL-17-ETHYNYL-17-HYDROXY- 1,2,6,7,8,9,10,11,12,13,14,15,16, 17- TETRADECAHYDROCYCLOPENTA[A] PHENANTHREN-3-ONE
13-beta-Ethyl-17alpha-ethynyl-17beta-hydroxygon-4-en-3-one
13-b-Ethyl-17a-ethynyl-17b-hydroxygon-4-en-3-one
13-Ethyl-17-a-ethynyl-17-b-hydroxy-4-gonen-3-one
13-Ethyl-17-a-ethynylgon-4-en-17-b-ol-3-one
13-Ethyl-17-alpha-ethynyl-17-beta-hydroxy-4-gonen-3-one
13-Ethyl-17-alpha-ethynylgon-4-en-17-beta-ol-3-one
13-Ethyl-17-α-ethynyl-17-β-hydroxy-4-gonen-3-one
13-Ethyl-17-α-ethynylgon-4-en-17-β-ol-3-one
13-Β-ethyl-17α-ethynyl-17β-hydroxygon-4-en-3-one
17-a-Ethinyl-13-b-ethyl-17-b-hydroxy-4-estren-3-one
17a-Ethynyl-13b-ethyl-3-oxo-4-estren-17b-ol
17-a-Ethynyl-13-ethyl-19-nortestosterone
17a-Ethynyl-17-hydroxy-18-methylestr-4-en-3-one
17a-Ethynyl-18-homo-19-nortestosterone
17-alpha-Ethinyl-13-beta-ethyl-17-beta-hydroxy-4-estren-3-one
17alpha-Ethynyl-13beta-ethyl-3-oxo-4-estren-17beta-ol
17-alpha-Ethynyl-13-ethyl-19-nortestosterone
17alpha-Ethynyl-17-hydroxy-18-methylestr-4-en-3-one
17alpha-Ethynyl-18-homo-19-nortestosterone
17-Ethynyl-18-methyl-19-nortestosterone
17-Α-ethinyl-13-β-ethyl-17-β-hydroxy-4-estren-3-one
17-Α-ethynyl-13-ethyl-19-nortestosterone
17Α-ethynyl-13β-ethyl-3-oxo-4-estren-17β-ol
17Α-ethynyl-17-hydroxy-18-methylestr-4-en-3-one
17Α-ethynyl-18-homo-19-nortestosterone
18-Methyl-17-a-ethynyl-19-nortestosterone
18-Methyl-17-alpha-ethynyl-19-nortestosterone
18-Methyl-17-α-ethynyl-19-nortestosterone
18-Methylnorethisterone
Alcala brand OF levonorgestrel
ATHENTIA NEXT
Aventis pharma brand OF levonorgestrel
BAY86-5028
Berlex brand OF levonorgestrel
Capronor
Cerazet
D Norgestrel
D(-)-Norgestrel
D-Norgestrel
Duofem
EMERRES
EMERRES UNA
EZINELLE
FALLBACK SOLO
HER STYLE
Hexal brand OF levonorgestrel
HRA brand 1 OF levonorgestrel
HRA brand 2 OF levonorgestrel
|
ISTERANDA
Jadelle
JAYDESS
KYLEENA
L Norgestrel
Levonelle
LEVONELLE ONE STEP
LEVONELLE-2
Levonorgestrel
LÉVONORGESTREL
Lèvonorgestrel
Levonorgestrel alcala brand
Levonorgestrel berlex brand
Levonorgestrel hexal brand
Levonorgestrel paladin brand
Levonorgestrel wyeth brand
Levonorgestrelum
Levonova
LEVOSERT
LILETTA
L-Norgestrel
l-norgestrel|Norplant®
Microlut
Microluton
Microval
Mirena
Norgeston
NORGESTREL (-)-FORM
NorLevo
Norplant
Norplant 2
NORPLANT II
NORPLANT SYSTEM
Norplant2
Norplant-2
OPCICON ONE-STEP
Ovrette
Paladin brand OF levonorgestrel
Plan b
PLAN B ONE-STEP
Postinor
POSTINOR-2
Schering brand 1 OF levonorgestrel
Schering brand 2 OF levonorgestrel
Schering brand 3 OF levonorgestrel
SKYLA
UPOSTELLE
Vikela
Women's capital brand OF levonorgestrel
WY-3707
WY-5104
Wyeth brand OF levonorgestrel
|
|
6 |
|
Pancrelipase |
Approved, Investigational |
Phase 4 |
|
53608-75-6 |
8519 |
Synonyms:
1,4-ALPHA-D- GLUCAN GLUCANOHYDROLASE
ACCELERASE
COTAZYM
COTAZYM-S
CREON
Endothall
Endothall dipotassium salt
Endothall disodium salt
Endothall disodium salt, (endo,endo)-isomer
Endothall, diammonium salt
ENTOLASE
ILOZYME
KU-ZYME HP
LIPANCREATIN
lipase
|
PA
Pancrealipase
PANCREASE
PANCREATIC ALPHA-AMYLASE PRECURSOR
Pancreatic extract pancrelipase
Pancreatic protease
Pancreatin
Pancreatinum
PANCRELIPASE
Pancrelipase (amylase
PANCRELIPASE (AMYLASE;LIPASE;PROTEASE)
protease)
VIOKASE
ZYMASE
|
|
7 |
|
Efavirenz |
Approved, Investigational |
Phase 4 |
|
154598-52-4 |
64139 |
Synonyms:
(-)-6-CHLORO-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-2H-3,1-benzoxazin-2-one
(S)-6-chloro-4-(Cyclopropylethynyl)-1,4-dihydro-(S)-6-chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one
(S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one
(S)-6-Chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-2H-3,1-benzoxazin-2-one
(S)-6-Chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo[D][1,3]oxazin-2-one
6-Chloro-4-(2-cyclopropyl-1-ethynyl)-4-trifluoromethyl-(4S)-1,4-dihydro-2H-benzo[D][1,3]oxazin-2-one
Bristol-myers squibb brand OF efavirenz
DMP 266
DMP-266
DMP-266|DMP266|EFV|L-743,726|L-743726|Stocrin®|Sustiva®
Du pont brand OF efavirenz
|
Efavirenz
Éfavirenz
Efavirenz, (R)-isomer
Efavirenz, (S)-isomer
Efavirenzum
EFV
Merck sharp and dohme brand OF efavirenz
Stocrin
Sustiva
SUSTIVA 600
United drug brand OF efavirenz
|
|
8 |
|
Ampicillin |
Approved, Vet_approved |
Phase 4 |
|
69-53-4 |
6249 |
Synonyms:
(2S,5R,6R)-6-[[(2R)-2-Amino-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
(2S,5R,6R)-6-{[(2R)-2-amino-2-phenylacetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
(2S,5R,6R)-6-{[(2R)-2-amino-2-phenylacetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
(2S,5R,6R)-6-{[(2R)-2-amino-2-phenylethanoyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
(2S,5R,6R)-6-{[(2R)-2-amino-2-phenylethanoyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylIC ACID
(2S,6R)-6-{[(2R)-2-amino-2-phenylethanoyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
(2S,6R)-6-{[(2R)-2-amino-2-phenylethanoyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
6-(a-Aminophenylacetamido)penicillanic acid
6-(D(-)-alpha-Aminophenylacetamido)penicillanic acid
6-(D-(2-Amino-2-phenylacetamido))-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylate
6-(D-(2-Amino-2-phenylacetamido))-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid
6-[(Aminophenylacetyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 9ci
6-D(-)-alpha-Aminophenylacetamido-penicillanic acid
ABPC
Acillin
Adobacillin
Alpen
alpha-Aminobenzylpenicillin
Amblosin
Amcill
Amfipen
Amfipen V
Aminobenzyl penicillin
Aminobenzylpenicillin
Amipenix S
AMP
Ampen
AMPI
Ampi-bol
Ampichel
Ampicil
Ampicilina
AMPICILLIN
Ampicillin (anhydrous)
Ampicillin acid
Ampicillin anhydrate
Ampicillin anhydrous
Ampicillin base
Ampicillin sodium
Ampicillin trihydrate
Ampicillin, anhydrous
AMPICILLIN/AMPICILLIN TRIHYDRATE
Ampicillina
Ampicilline
Ampicillinum
Ampi-co
Ampifarm
Ampikel
AMPILAR
Ampimed
Ampipenin
Ampiscel
Ampisyn
Ampi-tab
Ampivax
Ampivet
Amplacilina
Amplin
Amplipenyl
Amplisom
Amplital
Anhydrous ampicillin
Antibiotic KS R1
Antibiotic KS-R1
AP
Austrapen
AY 6108
AY-6108
Bayer 5427
Binotal
Bonapicillin
Britacil
BRITCIN
BRL 1341
BRL-1341
Campicillin
Cimex
Copharcilin
D-(-)-6-(a-Aminophenylacetamido)penicillanate
D-(-)-6-(a-Aminophenylacetamido)penicillanic acid
D-(-)-6-(alpha-Aminophenylacetamido)penicillanate
D-(-)-6-(alpha-Aminophenylacetamido)penicillanic acid
D-(-)-6-(Α-aminophenylacetamido)penicillanate
D-(-)-6-(Α-aminophenylacetamido)penicillanic acid
D-(−)-6-(Α-AMINOPHENYLACETAMIDO)PENICILLANIC ACID
D-(-)-alpha-Aminobenzylpenicillin
D-(-)-alpha-Aminopenicillin
|
D-(-)-Ampicillin
D-(−)-AMPICILLIN
D-a-Aminobenzylpenicillin
D-Ampicillin
D-Cillin
Delcillin
Deripen
Divercillin
Doktacillin
Duphacillin
Geocillin
Grampenil
Guicitrina
Guicitrine
KS-R1
KS-R1, Antibiotic
Lifeampil
Magnapen
Marcillin
Morepen
Norobrittin
Novo-ampicillin
NSC 528986
NSC-528986
Nuvapen
Olin kid
Omnipen
OMNIPEN-N
Orbicilina
P-50
Pen a
Pen ampil
Penbristol
Penbritin
PENBRITIN-S
Penbrock
Penicillin, aminobenzyl
Penicline
Penimic
Pensyn
Pentrex
Pentrexl
Pentrexyl
Pentritin
Pfizerpen a
PFIZERPEN-A
Polycillin
POLYCILLIN-N
POLYCILLIN-PRB
Ponecil
Princillin
Principen
PRINCIPEN '125'
PRINCIPEN '250'
PRINCIPEN '500'
PROBAMPACIN
Qidamp
Racenacillin
Ro-ampen
Rosampline
Roscillin
Semicillin
Servicillin
SK-Ampicillin
Sodium, ampicillin
Sumipanto
Supen
Synpenin
Texcillin
Tokiocillin
Tolomol
Totacillin
TOTACILLIN-N
Totalciclina
Totapen
Trifacilina
Trihydrate, ampicillin
Ukapen
Ultrabion
Ultrabron
Vampen
Viccillin
Vidocillin
Vidopen
WY 5103
Wypicil
|
|
9 |
|
Sultamicillin |
Approved, Investigational |
Phase 4 |
|
76497-13-7 |
2175 |
Synonyms:
2-Amino-N-{2-[({3,3-dimethyl-4,4,7-trioxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carbonyloxy}methoxy)carbonyl]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptan-6-yl}-2-phenylethanimidate
Sultamicilina
|
Sultamicillin
Sultamicillinum
|
|
10 |
|
Sulbactam |
Approved |
Phase 4 |
|
68373-14-8 |
5316 |
Synonyms:
(2S,5R)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid 4,4-dioxide
(2S,5R)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid 4,4-dioxide
Bétamaze
Combactam
Penicillanic acid 1,1-dioxide
Penicillanic acid sulfone
|
Sodium, sulbactam
Sulbactam
Sulbactam sodium
Sulbactamum
Sulfone, penicillanic acid
|
|
11 |
|
Insulin detemir |
Approved |
Phase 4 |
|
169148-63-4 |
16137271 |
Synonyms:
Detemir
INS LEVEMIR
INSULIN DETEMIR
INSULIN DETEMIR RECOMBINANT
Insulin,detemir,human
Insulina detemir
|
LEVEMIR
LEVEMIR FLEXPEN
LEVEMIR FLEXTOUCH
LEVEMIR INNOLET
LEVEMIR PENFILL
NN-304
|
|
12 |
|
Anesthetics, Local |
|
Phase 4 |
|
|
|
13 |
|
Antineoplastic Agents, Hormonal |
|
Phase 4 |
|
|
|
14 |
|
Androgens |
|
Phase 4 |
|
|
|
15 |
|
Omega 3 Fatty Acid |
|
Phase 4 |
|
|
|
16 |
|
Gastrointestinal Agents |
|
Phase 4 |
|
|
|
17 |
|
Hypoglycemic Agents |
|
Phase 4 |
|
|
|
18 |
|
Contraceptives, Postcoital |
|
Phase 4 |
|
|
|
19 |
|
Ulipristal acetate |
|
Phase 4 |
|
126784-99-4 |
13559282 130904 |
Synonyms:
(11BETA,17ALPHA)-17-ACETYL-11-[4-(DIMETHYLAMINO)PHENYL]-3-OXOESTRA-4,9-DIEN-17-YL ACETATE
14-Acetyl-17-[4-(dimethylamino)phenyl]-15-methyl-5-oxotetracyclo[8.7.0.0,.0,]heptadeca-1,6-dien-14-yl acetic acid
17-ACETOXY-11-(4-N,N-DIMETHYLAMINOPHENYL)PREGNA-4,9-DIENE-3,20-DIONE
CDB 2914
CDB-2914
CDB-2914|EllaOne®|VA2914
ELLA
ELLAONE
|
ESMYA
PGL-4001
RTI-3021-012
ULIPRISTAL ACET
ULIPRISTAL ACETATE
Ulipristal acetic acid
VA2914
VA-2914
|
|
20 |
|
Contraceptives, Oral |
|
Phase 4 |
|
|
|
21 |
|
Contraceptive Agents |
|
Phase 4 |
|
|
|
22 |
|
Liver Extracts |
|
Phase 4 |
|
|
|
23 |
|
Pancreatin |
|
Phase 4 |
|
|
|
24 |
|
Raltegravir Potassium |
|
Phase 4 |
|
|
|
25 |
|
Integrase Inhibitors |
|
Phase 4 |
|
|
|
26 |
|
Antiviral Agents |
|
Phase 4 |
|
|
|
27 |
|
Anti-Retroviral Agents |
|
Phase 4 |
|
|
|
28 |
|
Anti-Infective Agents |
|
Phase 4 |
|
|
|
29 |
|
Anti-HIV Agents |
|
Phase 4 |
|
|
|
30 |
|
HIV Protease Inhibitors |
|
Phase 4 |
|
|
|
31 |
|
HIV Integrase Inhibitors |
|
Phase 4 |
|
|
|
32 |
|
Reverse Transcriptase Inhibitors |
|
Phase 4 |
|
|
|
33 |
|
protease inhibitors |
|
Phase 4 |
|
|
|
Synonyms:
|
34 |
|
Anti-Bacterial Agents |
|
Phase 4 |
|
|
|
35 |
|
Antibiotics, Antitubercular |
|
Phase 4 |
|
|
|
36 |
|
Insulin, Globin Zinc |
|
Phase 4 |
|
|
|
37 |
|
Insulin |
|
Phase 4 |
|
|
|
Synonyms:
AFREZZA
EXUBERA
HUMULIN
HUMULIN BR
HUMULIN R
HUMULIN R KWIKPEN
HUMULIN R PEN
INS HUMULIN R
INSULIN
INSULIN (HUMAN)
INSULIN BOVINE
INSULIN BOVINE INSULIN
|
INSULIN HUMAN
INSULIN HUMAN (BIOSYNTHESIS)
INSULIN HUMAN (SYNTHESIS)
INSULIN RECOMBINANT HUMAN
INSULIN RECOMBINANT PURIFIED HUMAN
INSUMAN INFUSAT
MYXREDLIN
NOVOLIN
NOVOLIN R
VELOSULIN
VELOSULIN BR
VELOSULIN BR HUMAN
|
|
38 |
|
beta-Lactamase Inhibitors |
|
Phase 4 |
|
|
|
39 |
|
Zinc cation |
Approved, Experimental, Investigational |
Phase 2, Phase 3 |
|
7440-66-6, 23713-49-7 |
32051 |
Synonyms:
alpha D Mannosidase
alpha D Mannoside mannohydrolase
alpha Mannosidase
alpha Mannosidase b
alpha-D-Mannosidase
alpha-D-Mannoside mannohydrolase
alpha-Mannosidase
alpha-Mannosidase, lysosomal
alpha-Mannosidase, neutral
Dietary zinc
LAMAN
Lysosomal alpha mannosidase
Lysosomal alpha-mannosidase
Mannohydrolase, alpha-D-mannoside
Mannosidase b, alpha
Neutral alpha mannosidase
|
Neutral alpha-mannosidase
Topostin b
Zinc cation
ZINC ion
Zinc ion(2+)
Zinc(2+)
Zinc(II)
Zinc, chelated
Zinc, elemental
Zinc, ion (ZN2+)
zinc|zinc ion
Zincum metallicum
Zn
ZN(2+)
ZN(II)
ZN2+
|
|
40 |
|
Zinc sulfate |
Approved, Investigational |
Phase 2, Phase 3 |
|
7733-02-0 |
|
Synonyms:
Zinc sulfate (anhydrous)
Zinc sulfate anhydrous
Zinc sulfate, anhydrous
|
Zinc sulphate
Zinc sulphate anhydrous
Zinc sulphate, anhydrous
|
|
41 |
|
Dermatologic Agents |
|
Phase 2, Phase 3 |
|
|
|
42 |
|
Licogliflozin |
Investigational |
Phase 2 |
|
1291094-73-9 |
52913524 |
Synonyms:
example 62 [WO2011048112A1]|LIK-066|LIK066
LICOGLIFLOZIN
|
|
|
43 |
|
Indole-3-carbinol |
Investigational |
Phase 2 |
|
700-06-1 |
3712 |
Synonyms:
(1H-Indol-3-yl)methanol
1H-indol-3-Ylmethanol
1H-Indole-3-methanol
3-(Hydroxymethyl)indole
3-Hydroxymethylindole
3-hydroxymethylindole|3-indolemethanol|3-indolylcarbinol|I3C
3-Indolecarbinol
|
3-Indolylcarbinol
3-Indolylmethanol
I3c CPD
Indinol
INDOLE-3-CARBINOL
Indole-3-methanol
NSC-525801
|
|
44 |
|
Indole |
Experimental |
Phase 2 |
|
120-72-9 |
798 |
Synonyms:
1-Azaindene
1-Benzazole
2,3-Benzopyrrole
Benzo[b]pyrrole
|
|
|
45 |
|
Sodium-Glucose Transporter 2 Inhibitors |
|
Phase 2 |
|
|
|
46 |
|
Estrogens |
|
Phase 2 |
|
|
|
47 |
|
Protective Agents |
|
Phase 2 |
|
|
|
48 |
|
Pravastatin |
Approved |
Phase 1 |
|
81093-37-0 |
54687 |
Synonyms:
(+)-(3R,5R)-3,5-Dihydroxy-7-[(1S,2S,6S,8S,8ar)-6-hydroxy-2-methyl-8-{[(S)-2-methylbutyryl]oxy}-1,2,6,7,8,8a-hexahydro-1-naphthyl]heptanoate
(+)-(3R,5R)-3,5-Dihydroxy-7-[(1S,2S,6S,8S,8ar)-6-hydroxy-2-methyl-8-{[(S)-2-methylbutyryl]oxy}-1,2,6,7,8,8a-hexahydro-1-naphthyl]heptanoic acid
(3R,5R)-7-[(1S,2S,6S,8S,8AR)-6-hydroxy-2-methyl-8-[(2S)-2-methylbutanoyl]oxy-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic acid
3beta-Hydroxycompactin
Apo pravastatin
Apo-pravastatin
Apotex brand OF pravastatin sodium
Aventis brand OF pravastatin sodium
Bristacol
Bristol-myers squibb brand OF pravastatin sodium
C10AA03
Compactin
Elisor
Eptastatin
Esteve brand OF pravastatin sodium
Juste brand OF pravastatin sodium
Lin pravastatin
Lin-pravastatin
Linson pharma brand OF pravastatin sodium
Lipemol
Liplat
Lipostat
Lipostat®|Pravachol®|pravastatin sodium
Mevalothin
Mevalotin
Mevastatin
Mevinolin
Nu pravastatin
Nu-pharma brand OF pravastatin sodium
Nu-pravastatin
|
Oliprevin
Prareduct
Pravachol
Pravacol
Pravaselect
Pravasin
PRAVASTATIN
Pravastatin acid
Pravastatin monosodium salt, (6 beta)-isomer
Pravastatin sodium
Pravastatin sodium salt
Pravastatin tert octylamine salt
Pravastatin tert-octylamine salt
Pravastatin, (6 beta)-isomer
Pravastatina
Pravastatina [Spanish]
Pravastatine
Pravastatine [French]
Pravastatinum
Pravastatinum [Latin]
Pravator
RMS 431
RMS-431
Sankyo brand OF pravastatin sodium
Selectin
Selektine
Selipran
Sodium salt, pravastatin
Squibb brand OF pravastatin sodium
Vasten
|
|
49 |
|
Glucagon |
Approved |
Phase 1 |
|
16941-32-5 |
16133228 16186314 |
Synonyms:
[<sup>125</sup>I]-glucagon
GCG(53-81)
GLUCAGEN HYPOKIT
GLUCAGON
Glucagon (recombinant dna origin)
GLUCAGON EMERGENCY KIT
|
GLUCAGON RECOMBINANT
Glucagon, human
Glucagon, porcine
GLUCAGONE
GLUCAGONUM
HSQGTFTSDYSKYLDSRRAQDFVQWLMNT
|
|
50 |
|
Resveratrol |
Investigational |
Phase 1 |
|
501-36-0 |
445154 |
Synonyms:
(E)-2-(3,5-Dihydroxyphenyl)-1-(4-hydroxyphenyl)ethene
(E)-3,4',5-Trihydroxystilbene
(E)-3,4’,5-Trihydroxystilbene
(e)-5-(2-(4-Hydroxyphenyl)ethenyl)-1,3-benzenediol
(E)-5-(2-(4-hydroxyphenyl)ethenyl)-1,3-benzenediol(E)-5-(2-(4-hydroxyphenyl)ethenyl)-1,3-benzenediol
(E)-5-(p-Hydroxystyryl)resorcinol
(E)-5-[2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol
(e)-Resveratrol
3,4',5-Stilbenetriol
3,4',5-stilbenetriol|3,5,4'-trihydroxystilbene|trans-resveratrol
3,4',5-Trihydroxystilbene
3,4',5-Trihydroxy-trans-stilbene
3,4’,5-Stilbenetriol
3,4’,5-Trihydroxystilbene
3,4’,5-Trihydroxy-trans-stilbene
|
3,5,4'-Trihydroxystilbene
3,5,4'-TRIHYDROXY-TRANS-STILBENE
5-[(1E)-2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol
5-[(e)-2-(4-Hydroxyphenyl)vinyl]benzene-1,3-diol
BIA 6-512
BIA-6-512
NSC-327430
Resveratrol
SRT 501
SRT-501
trans Resveratrol
trans-3,4',5 - Trihydroxystilbene
trans-3,5,4’-Trihydroxystilbene
trans-3,5,4'-Trihydroxystilbene
trans-Resveratrol
|
|
Interventional clinical trials:
(show top 50)
(show all 164)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
Correlation of Postoperative VAS Values and Body Mass Index in Patients Undergoing Abdominal Surgery: A Clinical Trial |
Unknown status |
NCT02017314 |
Phase 4 |
Morphine |
2 |
Analysis of Body Mass Index in Central Precocious Puberty(CPP) Patients Treated With Leuprolide Acetate |
Unknown status |
NCT02974270 |
Phase 4 |
Leuprolide |
3 |
A Pilot Phase IV Study to Evaluate Variation in Bone Mineral Density, Lean and Fat Body Mass Index Measured by Dual-energy X-ray Absorptiometry in Patients With Prostate Cancer Without Bone Metastasis Treated With Degarelix |
Unknown status |
NCT03202381 |
Phase 4 |
Degarelix |
4 |
The Effect of Body Mass Index, Intra-abdominal Pressure, Abdominal Girth and Waist Circumference on Sensory Block Level After Single-shot Spinal Anesthesia for Cesarean Section |
Unknown status |
NCT03164096 |
Phase 4 |
Bupivacaine Hydrochloride |
5 |
Energy-restricted, n-3 Polysaturated Fatty Acids-rich Diet Improves the Clinical Response to Immuno-modulating Drugs in Obese Patients With Plaque-type Psoriasis: a Randomized Control Clinical Trial. |
Completed |
NCT01876875 |
Phase 4 |
|
6 |
Pharmacokinetics of Levonorgestrel and Ulipristal Acetate Emergency Contraception in Women With Normal and Obese Body Mass Index |
Completed |
NCT02689804 |
Phase 4 |
LNG-EC;UPA-EC |
7 |
Double-Blind, Multicenter, Randomized, Placebo-Controlled, Parallel-Group Study to Investigate the Effect of Creon 25000 Minimicrospheres on Body Mass Index (BMI) in Patients After Gastrectomy |
Completed |
NCT00160186 |
Phase 4 |
Pancreatin;Placebo |
8 |
Effect on Liver Fat, Adipose Tissue and Metabolic Parameters When Switching a Protease Inhibitor or Efavirenz to Once Daily Raltegravir in HIV+ Patients With Body Mass Index Over 25 kg/m2 and With at Least One Metabolic Syndrome Component |
Completed |
NCT03374358 |
Phase 4 |
Raltegravir |
9 |
Phase IV Study of Determining the Efficacy of Ampicillin/Sulbactam Combination as Antibiotic Prophylaxis During Breast Cancer Surgery in Patients With a Body Mass Index (BMI) Over 25. |
Completed |
NCT00356148 |
Phase 4 |
Ampicillin/Sulbactam |
10 |
A 26-week Randomised, Controlled, Open Label, Multicentre, Multinational, Treat to Target Trial Investigating the Impact of Dietary Intervention on Weight Change and the Relationship Between Weight Change and Baseline Body Mass Index (BMI) in Subjects With Type 2 Diabetes Inadequately Controlled on Oral Antidiabetic Drugs (OADs) Initiating Insulin Therapy With Insulin Detemir in Combination With Metformin (Levemir DIET) |
Completed |
NCT01232491 |
Phase 4 |
Insulin detemir |
11 |
High Protein Diet , Adiponectin and Inflammatory Factors |
Completed |
NCT01886495 |
Phase 3 |
|
12 |
Effect of High Protein Diet on Cardiovascular Diseases Risk Factors Among Overweight and Obese Children |
Completed |
NCT01886482 |
Phase 3 |
|
13 |
High Protein Diet , CRP and CVD Risk Factors |
Completed |
NCT01763528 |
Phase 3 |
|
14 |
Effects of Zinc Supplementation on Weight, Body Mass Index (BMI), Waist Circumference, Fat Mass and Lean Mass, Apelin and Inflammatory Markers in Obese Individuals |
Completed |
NCT02516475 |
Phase 2, Phase 3 |
|
15 |
Effect of Mindful Eating on Body Mass Index and Cardiovascular Risk Markers in Obese Adolescents: A Pilot Randomized Clinical Trial |
Completed |
NCT01764113 |
Phase 3 |
|
16 |
An Endometrial Cancer Chemoprevention Study of Metformin Versus No Treatment in Women With a Body Mass Index (BMI) >/= 30 kg.m2 and Hyperinsulinemia |
Active, not recruiting |
NCT01697566 |
Phase 3 |
Metformin |
17 |
A Randomized, Double-blind, Placebo-controlled, Parallel Group, 2-part Study Investigating the Effect of LIK066 on Body Weight in Dysglycemic (Prediabetes or Type 2 Diabetes) and Normoglycemic Patients With Elevated Body Mass Index |
Completed |
NCT02470403 |
Phase 2 |
LIK066;Placebo |
18 |
A 61-day Randomized, Double Blind, Placebo-controlled Trial to Assess the Safety and Efficacy of Three Doses of HU6 in Subjects With Elevated Liver Fat and High Body Mass Index (28 to 45 kg/m2) |
Completed |
NCT04874233 |
Phase 2 |
HU6;Placebo |
19 |
A Phase IIa Trial of Metformin for Colorectal Cancer Risk Reduction Among Patients With a History of Colorectal Adenomas and Elevated Body Mass Index |
Completed |
NCT01312467 |
Phase 2 |
metformin hydrochloride |
20 |
Intermittent Fasting for Patients With HER2- Negative and ER/PR <10% Breast Cancer and Body Mass Index >= 25 Receiving Neoadjuvant Chemotherapy |
Recruiting |
NCT05327608 |
Phase 2 |
|
21 |
Effects of Dietary Indole-3-Carbinol on Estrogen Metabolites Across a Wide Range of Body Mass Index: Implications for the Prevention of Endometrial Cancer in Obese Women |
Terminated |
NCT00988845 |
Phase 2 |
|
22 |
Effect of Injection Site on the Pharmacokinetics and Pharmacodynamics of Single Subcutaneous Doses of LY2605541 in Healthy Subjects, and Impact of Body Mass Index and Age on the Pharmacokinetics of LY2605541 |
Completed |
NCT01818245 |
Phase 1 |
LY2605541 |
23 |
Pilot Study of Resveratrol in Postmenopausal Women With High Body Mass Index |
Completed |
NCT01370889 |
Phase 1 |
resveratrol |
24 |
Pilot Trial of Pravastatin as a Novel Prophylactic Medicine to Reduce Endothelial Injury in Pediatric Patients With Elevated Body Mass Index |
Recruiting |
NCT05524246 |
Phase 1 |
Pravastatin |
25 |
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VK2735, a Dual Glucagon-like Peptide-1 and Gastric Inhibitory Polypeptide Receptor Agonist, in Healthy Adults and Otherwise Healthy Adults Who Have an Increased Body Mass Index |
Recruiting |
NCT05203237 |
Phase 1 |
|
26 |
A Phase 1, First-in-Human, Double-blind, Placebo-controlled, Single-and Multiple-Ascending Oral Dose, Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study of GM-60106 in Healthy Adults and Otherwise Healthy Adults With an Increased Body Mass Index and Markers of Non-Alcoholic Fatty Liver Disease |
Enrolling by invitation |
NCT05517564 |
Phase 1 |
GM-60106 |
27 |
A Comparative Effectiveness Research Study Comparing Changes in Body Composition and Parent Ratings of Quality of Life in 5-19 Year Olds as a Function of Participation in One of Four Versions of the Good NEWS 4 Kids Program (GN4K) |
Unknown status |
NCT01855009 |
|
|
28 |
The Genetic Basis of the Influence of Dairy Product Intake on Body Measures in Children |
Unknown status |
NCT01831557 |
|
|
29 |
Correlation Between Body Mass Index and Gonadotrophin Secretions in Pcos Patients and Their Effect on Ivf Outcome (Randamized Control Trial) |
Unknown status |
NCT03291405 |
|
|
30 |
Assessment of the Effect of Obesity on Venous Puncture Pain |
Unknown status |
NCT03689205 |
|
|
31 |
Age and Gender Corrected Body Mass Index: When Preoperative Weight Loss and Underweight Are Becomming Clinically Significant in Esophagectomy for Cancer. |
Unknown status |
NCT01958697 |
|
|
32 |
Efficacy of Oral Vitamin D Supplementation in Reducing Body Mass Index and Lipid Profile in Adolescents and Young Adults in Colombia: a Pilot Clinical Trial Protocol Nested in the SIMBA Cohort |
Unknown status |
NCT04377386 |
|
|
33 |
Effect of Modified Laparoscopic Roux-en-Y Gastric Bypass Surgery on Type 2 Diabetics With Lower Body Mass Index in China |
Unknown status |
NCT02091323 |
|
|
34 |
The Relationship Between Transvaginal Ultrasound Endometrial Thickness and Body Mass Index and Pathology in Postmenopausal Bleeding |
Unknown status |
NCT03841916 |
|
|
35 |
Effect of Synbiotic Supplement on the Body Mass Index of Participants With Severe Obesity |
Unknown status |
NCT02958644 |
|
|
36 |
The Difference Seen in Granulosa Cells and Immature Oocytes in IVF Treated Patients Sorted by Body Mass Index (BMI) |
Unknown status |
NCT03020173 |
|
|
37 |
A Pragmatic, Randomised, Controlled, Trial of the Effect of the Counterweight Plus Weight Management Programme in Uncontrolled Asthma Associated With Elevated Body Mass Index |
Unknown status |
NCT03858608 |
|
|
38 |
A Mixed Retrospective-prospective, Observational Study Evaluating the Efficacy of Counselling in a Remote Setting Compared to an In-person Setting on Weight Loss, in Obese Patients With Body Mass Index > 35 Kg/m2 and Enrolled in the Behaviour Modification Program at the Bariatric Centre of Excellence at St Joseph's Healthcare Hamilton. |
Unknown status |
NCT04658550 |
|
|
39 |
Body Mass Index (BMI) and Quality of Life (QoL) in Cancer Patients |
Unknown status |
NCT03873064 |
|
|
40 |
The Association Between Periodontal Health Status, Body Mass Index and Quality of Diet in a Sample of Adult Egyptian Patients. A Hospital Based Cross-sectional Study |
Unknown status |
NCT04557670 |
|
|
41 |
Prospective, Observational Study of Evaluation of Body Mass Index and Eating Behaviour Changes in Female Patients With Fibromyalgia Under Medical Treatment |
Unknown status |
NCT03394898 |
|
|
42 |
Effect of Increased Body Mass Index on Auditory Function |
Unknown status |
NCT03172663 |
|
|
43 |
Obesity Index That Better Predict Ovarian Response: Body Mass Index, Waist Circumference, Waist Hip Ratio, or Waist Height Ratio in Women Undergoing ICSI |
Unknown status |
NCT02520765 |
|
|
44 |
Developmental Pathways to Metabolic Diseases: Metabolic Physiology, Epigenetics and Body Composition in Healthy Overweight and Obese Subjects With a Fixed Range of Body Mass Index in Singapore - To Investigate the Influence of Ethnicity |
Unknown status |
NCT00988819 |
|
|
45 |
Impact of Body Mass Index on Outcomes of Breast Cancer Management (Retrospective Study) |
Unknown status |
NCT03429504 |
|
|
46 |
The Relationship Between Genetics, Body Mass Index, Fat Intake, Fat Taste Sensitivity and Food Preference |
Unknown status |
NCT03666182 |
|
|
47 |
A Pragmatic, Randomised, Controlled, Trial of the Effect of a Tailored Pulmonary Rehabilitation Package in Uncontrolled Asthma Associated With Elevated Body Mass Index |
Unknown status |
NCT03630432 |
|
|
48 |
The Effect of Diet Counseling for Low Calorie-High Protein on the Body Composition (Weight, Body Mass Index, Fat Mass (kg), Fat Mass Percentage, Muscle Mass (kg), Muscle Mass Percentage, Inflammation Marker (High-sensitivity C-reactive Protein), and Oxidative Stress Marker (Malondialdehyde and Glutathione) in Obese People With Weight Cycling in Jakarta |
Unknown status |
NCT03374150 |
|
|
49 |
Cognitive Function and Body Mass Index in Children and Adolescents |
Unknown status |
NCT03963557 |
|
|
50 |
Can a Higher Body Mass Index and a Positive Stop Bang or Epworth Sleepiness Scale Questionnaire Predict Cardiorespiratory Adverse Events During Endoscopy: A Prospective Cohort Study |
Unknown status |
NCT03436381 |
|
|
|